SEC Company Response from InflaRx N.V. (IFRX) (CIK 0001708688) (IFRX) — May 2, 2018
InflaRx N.V. (IFRX) (CIK 0001708688)
Date: May 2, 2018 · CIK: 0001708688 · Accession: 0000950103-18-005708
AI Filing Summary & Sentiment
File numbers found in text: 333-224596
Show Raw Text
CORRESP
1
filename1.htm
InflaRx N.V.
Winzerlaer Str. 2
07745 Jena, Germany
May 2, 2018
Division of Corporation Finance
U.S. Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549-3628
Attn: Ms. Ada D. Sarmento
Ms. Erin Jaskot
Re:
InflaRx N.V.
Registration Statement on Form F-1
Registration No. 333-224596
Dear Ms. Sarmento and Ms. Jaskot:
Pursuant to Rule 461 under the Securities Act of 1933, as amended,
the undersigned registrant hereby requests that the effective date for the Registration Statement referred to above be accelerated
so that it will be declared effective at 4:00 p.m. Eastern Daylight Time on May 3, 2018 or as soon thereafter as is practicable.
By separate letter, the underwriters of the issuance of the securities being registered join in this request for acceleration.
Please do not hesitate to contact Sophia Hudson of Davis Polk
& Wardwell LLP at (212) 450-4762 with any questions or comments with respect to this letter.
[Signature Page Follows]
Sincerely,
INFLARX N.V.
By:
/s/ Niels Riedemann
Name: Niels Riedemann
Title: Chief Executive Officer
Via EDGAR
CC: Sophia Hudson, Davis Polk & Wardwell LLP